Showing results (2171-2180 of 5,703) with videos related to
Sort By:
Pageof 571
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2018
A randomized, single ascending dose study of intravenous BIIB092 in healthy participantsIrfan A Qureshi, Giridhar Tirucherai, Michael K Ahlijanian, et al.Ochsner Journal|January 7, 2020
Surge in Fentanyl Toxicity Deaths in Jefferson Parish, LA, 2013-2018Kayla Noto, Dana Troxclair, Melva Williams, et al.The Journal of Parasitology|March 17, 2006
Schistosoma mansoni dermaseptin-like peptide: structural and functional characterizationGerry A P Quinn, Raymond Heymans, Franchesca Rondaj, et al.The Journal of Supportive Oncology|August 9, 2006
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practiceThomas Delea, James McKiernan, Jane Brandman, et al.Medical Teacher|September 5, 2013
Variation in personality traits of medical students between schools of medicineIan Wilson, Barbara Griffin, Lisa Lampe, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2014
High-dose-rate brachytherapy with two or three fractions as monotherapy in the treatment of locally advanced prostate cancerPeter Hoskin, Ana Rojas, Peter Ostler, et al.Journal of Clinical Periodontology|September 18, 2014
Incidence of peri-implant mucositis and peri-implantitis in edentulous patients with an implant-retained mandibular overdenture during a 10-year follow-up periodHenny J A Meijer, Gerry M Raghoebar, Yvonne C M de Waal, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicityPeter Hoskin, Ana Rojas, Peter Ostler, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|October 3, 2013
A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humansFrida Gustafsson, Alison J Foster, Sunil Sarda, et al.Human Vaccines & Immunotherapeutics|July 12, 2016
Pembrolizumab (Keytruda)Gerry Kwok, Thomas C C Yau, Joanne W Chiu, et al.Pageof 571